Aktie A12A5F FENNEC PHARMACEUTICALS INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Fennec Pharmaceuticals Inc. Toronto S.E.

Aktien

A12A5F

CA31447P1009

FRX

Markt geschlossen - Toronto S.E.
Andere Börsenplätze
 21:59:59 17.07.2024 		% 5 Tage % 1. Jan.
9,1 CAD -0,55 % Intraday Chart für Fennec Pharmaceuticals Inc. +12,62 % -39,97 %
02.07. MT Newswires Wochenend-Aktien zum Beobachten: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris MT
01.07. Fennec Pharmaceuticals Inc. kündigt Änderungen in der Geschäftsführung an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
MT Newswires Weekend Stocks To Watch: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc. Announces Executive Changes
Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals : Corporate Presentation May 2024
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue
Fennec Pharmaceuticals Brief: Company Says Has Approximately US$51 Million in Cash, Cash Equivalents, and Investment Securities
Fennec Pharmaceuticals Brief: Achieved Q1 2024 Total Net Revenues of US$25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing
Fennec Pharmaceuticals : Corporate Presentation March 2024
Wedbush on Fennec's Q4
Fennec Pharmaceuticals up 3.2% in US Premarket, Reports Narrower Q4 Loss of $0.10 Per Share
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A12A5F Aktie
  4. A12A5F Aktie
  5. Nachrichten Fennec Pharmaceuticals Inc.
  6. Andere Sprachen